ACS

1. Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction Circulation. 1998;97:2202-2212
2. Antman EM, et. al., The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI JAMA. 2000;284(7):835-842
3. Cannon CP, et. al., Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes N Engl J Med 2004; 350:1495-1504
4. COMMIT Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo controlled trial Lancet 2005; 366: 1622–32
5. Eagle KA, et. al., A Validated Prediction Model for All Forms of Acute Coronary Syndrome JAMA. 2004;291(22):2727-2733
6. Hansen ML, et. al., Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation Arch Intern Med. 2010;170(16):1433-1441
7. Hochman JS, et.al., Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock N Eng J Med 1999:341(9):625-634
8. Jeremias A, et. al, Narrative Review: Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded Ann Intern Med. 2005;142:786-791.
9. Keeley, EC, et. al., Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 2003; 361: 13–20.
10. Mathews R, et. al., In-Hospital Major Bleeding During ST-Elevation and Non–ST-Elevation Myocardial Infarction Care: Derivation and Validation of a Model from the ACTION Registry®-GWTG™ Am J Cardiol 2011;107:1136–1143
11. CREATE-ECLA, Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction JAMA. 2005;293(4):437-446.
12. Petersen, JL, et. al., Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary SyndromesJAMA. 2004;292(1):89-96.
13. Pfeffer MA, et. al., Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both N Engl J Med 2003; 349:1893-1906
14. Pitt B, et. al., Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction N Engl J Med 2003;348:1309-21.
15. Sgarbossa EB, Electrocardiographic Diagnosis of Evolving Acute Myocardial Infarction in the Presence of Left Bundle-Branch Block N Engl J Med 1996; 334:481-487
16. Wallentin L, et. al., Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes N Engl J Med 2009; 361:1045-1057
17. Wittstein IS, et. al., Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress N Engl J Med 2005; 352:539-548
18. Trial Investigators, Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation N Engl J Med 2001; 345:494-502

Arrhythmia

1. AFFIRM Investigators, A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation, N Engl J Med 2002; 347:1825-1833
2. AVID Investigators, A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias N Engl J Med 1997; 337:1576-1584
3. Lip GY, et. al., Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation CHEST 2010;137(2):263-272.
4. McAlister FA, et. al., Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction A Systematic Review JAMA. 2007;297(22):2502-2514
5. Moss AJ, et. al., Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events N Engl J Med 2009; 361:1329-1338
6. Mitchell LB, et. al., Prophylactic Oral Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair JAMA. 2005;294(24):3093-3100.
7. Roy D, et. al., Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure N Engl J Med 2008; 358:2667-2677
8. Morrow JP, et. al., New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: What are our therapies likely to be by 2010 and beyond? Am Heart J 2007;154:824-9.
9. Matthew JR, et. al., The ROSE (Risk Stratification of Syncope in the Emergency Department) Study J Am Coll Cardiol 2010;55:713–21
10. SCD-HeFT Investigators, Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure N Engl J Med 2005; 352:225-237

Cardiac Risk

1. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary : A Report of the American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines Circulation. 2010;122:2748-2764
2. Berry JD, et. al., Lifetime Risks of Cardiovascular Disease N Engl J Med. 2012;366:321-9.
3. D'Agostino RB, et. al., General Cardiovascular Risk Profile for Use in Primary Care : The Framingham Heart Study Circulation 2008, 117:743-753
4. Lloyd-Jones DM, Cardiovascular Risk Prediction : Basic Concepts, Current Status, and Future Directions Circulation 2010, 121:1768-1777
5. Wilson PWF, et. al., Prediction of Coronary Heart Disease Using Risk Factor Categories Circulation 1998, 97:1837-1847

Congenital Heart Disease

1. Sreeran N, et. al., Changing role of non-invasive investigation in the preoperative assessment of congenital heart disease: a nine year experience Br Heart J 1990;63:345-9
2. Brickner ME, et. al., Congenital Heart Disease in Adults: First of Two Parts N Engl J Med 2000; 342:256-263
3. Brickner ME, et. al., Congenital Heart Disease in Adults: Second of Two Parts N Engl J Med 2000; 342:334-342
4. Humenberger M. et. al., Benefit of atrial septal defect closue in adults: impact on age European Heart Journal (2011) 32, 553–560
5. ESC Task Force, et.al., ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) European Heart Journal (2010) 31, 2915–2957
6. Khairy P, et. al., Changing Mortality in Congenital Heart Disease JACC 2010;56;1149-57
7. Mongeon FP, et. al., Congenitally Corrected Transposition of the Great Arteries JACC 2011:57;2008–2017
8. Kempny A, Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life—single centre experience and review of published data European Heart Journal (2012) 33, 1386–1396
9. Inuzuka R, et. al., Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults WithCongenital Heart Disease at Increased Mortality Risk in the Medium Term Circulation 2012, 125:250-259
10. Warnes CA, et. al., ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease JACC 2008:52;e143–e263
11. Bedard E., et. al., Adult congenital heart disease: a 2008 overview British Medical Bulletin 2008; 85: 151–180
12. Kantor PF, et. al., Pathophysiology and Management of Heart Failure in Repaired Congenital Heart Disease Heart Failure Clin 2010:6;497–506
13. Paranon, S., et. al., Ebstein’s anomaly of the tricuspid valve: from fetus to adult Heart 2008;94:237–243.
14. Khairy P., EP challenges in adult congenital heart disease Heart Rhythm 2008;5:1464–1472)
15. Tomaske M., et. al., Experience with Implantable Cardioverter-Defibrillator Therapy in Grown-Ups with Congenital Heart Disease PACE 2008; 31:S35–S37
16. Verheugt CL, et. al., Mortality in adult congenital heart disease European Heart Journal (2010) 31, 1220–1229
17. Dimopoulos K., et. al., Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension Circulation. 2010;121:20-25.
18. Sommer RJ, Pathophysiology of Congenital Heart Disease in the Adult Part I: Shunt Lesions Circulation. 2008;117:1090-1099.
19. Rhodes JF, et. al., Pathophysiology of Congenital Heart Disease in the Adult, Part II : Simple Obstructive Lesions Circulation. 2008;117:1228-1237
20. Sommer RJ, et. al., Pathophysiology of Congenital Heart Disease in the Adult Part III: Complex Congenital Heart Disease Circulation. 2008;117:1340-1350.
21. Rigatelli G, et. al., Primary Transcatheter Patent Foramen Ovale Closure Is Effective in Improving Migraine in Patients With High-Risk Anatomic and Functional Characteristics for Paradoxical Embolism J. Am. Coll. Cardiol. Intv. 2010;3;282-287
22. Norozi K., et. al., Relation of Systemic Ventricular Function Quantified by Myocardial Performance Index (Tei) to Cardiopulmonary Exercise Capacity in Adults After Mustard Procedure for Transposition of the Great Arteries Am J Cardiol 2005;96:1721–1725
23. Hudsmith LE, et. al., Transition of care from paediatric to adult services in cardiology Arch Dis Child 2007;92:927–930

Diabetes and Cardiovascular Disease

1. ACCORD Study Group, Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusN Engl J Med 2010;362:1575-85.
2. ACCORD Study Group, Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus, N Engl J Med 2010;362:1563-74.
3. ACCORD Study Group, Effects of Intensive Glucose Lowering in Type 2 Diabetes N Engl J Med 2008;358:2545-59.
4. ADVANCE Collaborative Group, Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesN Engl J Med 2008;358:2560-72.
5. Pignone M., et. al., Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: ADA/AHA/ACCF Scientific StatementCirculation 2010, 121:2694-2701.
6. Kosiborod M, McGuire DK, Glucose-Lowering Targets for Patients With Cardiovascular Disease: Focus on Inpatient Management of Patients With Acute Coronary SyndromesCirculation 2010, 122:2736-2744.
7. McGuire DK, et. al., New Drugs for the Treatment of Diabetes Mellitus Part I: Thiazolidinediones and Their Evolving Cardiovascular Implications Circulation 2008, 117:440-449.
8. Inzucchi SE, McGuire DK, New Drugs for the Treatment of Diabetes Part II: Incretin-Based Therapy and BeyondCirculation 2008, 117:574-584.
9. Drazner MH, et. al., Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure: The ESCAPE Trial Circ Heart Fail 2008;1;170-177.
10. Buse JB, et. al., Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: AHA/ADA Scientific Statement Circulation 2007, 115:114-126.
11. Duckworth W., et. al., Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesN Engl J Med 2009;360:129-39.

Heart Failure

1. Fanarow GC, et. al., Risk Stratification for In-Hospital Mortality in Acutely Decompensated Heart Failure Classification and Regression Tree Analysis JAMA. 2005;293:572-580
2. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults : A Report of the American College of CardiologyFoundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation. 2009;119:1977-2016
3. O'Conner CM, et. al., Effect of Nesiritide in Patients with Acute Decompensated Heart Failure N Engl J Med 2011;365:32-43
4. The ESCAPE Trial, Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness JAMA. 2005;294:1625-1633
5. Merha MR, et. al., Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006 J Heart Lung Transpl 2010:5;589-591
6. Stevenson LW, et. al., INTERMACS Profiles of Advanced Heart Failure: The Current Picture J Heart Lung Transplant 2009;28:535–41
7. Levy WC, et. al., The Seattle Heart Failure Model : Prediction of Survival in Heart Failure Circulation.2006;  113: 1424-1433
8. Nohria A., et. al., Medical Management of Advanced Heart Failure JAMA. 2002;287(5):628-640
9. Stewart GC, Mechanical Circulatory Support for Advanced Heart Failure : Patients and Technology in Evolution Circulation. 2012;125: 1304-1315

Interventional Cardiology

1. Tonino PAL, et. al., Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention N Engl J Med 2009; 360:213-224
2. Hirsch AT, ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease Circulation 2006, 113:e463-e654
3. Levine, GN, et. al., 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Circulation. 2011; 124: e574-e651
4. Leon MB, et. al., Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery N Engl J Med 2010;363:1597-1607.
5. Serruys PW, et. al., Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease N Engl J Med 2009;360:961-72.
6. Wright RS, et. al., 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/NonST-Elevation Myocardial Infarction J Am Coll Cardiol. 2011;57(19):1920-1959.